DM Farmacêutica Sold In Landmark OTC Deal

Dorsay Monange (DM) Farmacêutica, one of Brazil's leading over-the-counter (OTC) producers, is reportedly being sold to recently formed consumer products holding Hypermarcas. The price of the deal was initially reported at US$450mn, although this figure was quickly raised to US$700-750mn. The deal will make DM part of a broader consumer products holding and help expand its local market penetration, while positioning Hypermarcas to build a regional profile in the market - challenging multinationals in Brazil's tough OTC

To read the full article, please choose one of the following options: